The coronavirus crisis, which was a shockingly unprecedented experience for the economy, was an opportunity for profit from buying and selling stocks – both in the domestic market and on global capital markets. One small investor told us that at the beginning of the crisis, when stock owners were panicking and mass-selling their ownership stakes, he did the exact opposite: at that moment, he decided to buy. Specifically, one of the stocks he traded was that of the American airline Delta Airlines, which he bought for $24 per share, and which was worth $62 before the major drop. He sold it in April, after about two months, for $37. Since he invested ten thousand US dollars in that transaction, he made a profit of $5,400. Our interlocutor had not invested in stocks before, but he said that he was prompted to do so because he had witnessed two previous stock market crashes and recoveries, the first time on September 11, 2001, and then during the 2009 crisis, so he tried to take advantage of the coronavirus crisis for profit and succeeded in that endeavor.
Vlatko Kesegić, a broker and investment advisor at Fima Securities, emphasizes that anyone who was brave enough in March to engage capital and buy stocks, at a time when a major crash was recorded on all global stock exchanges, could have made a good profit. Younger clients most often bought shares of technology companies. From the period of the lowest prices in March, Zoom Video Communications, Inc. has increased by 200 percent, and since the beginning of the year by as much as 250 percent. The company was listed on the stock exchange in August 2019, when the share price was $36, and today it is around $240, which means that investors could have made an incredible 670 percent profit on Zoom!
Another company that was a big winner of the crisis is Amazon. As more and more commerce was based on online sales, Amazon has increased by 41.5 percent since the beginning of the year. The third winner, according to Kesegić, was Netflix, as most people stayed home in isolation, which drastically increased the number of its subscribers, and thus the share price, which rose by 35 percent.
The low oil price, especially its negative indicators, attracted many clients as everyone expected a price recovery, which did happen.
Investors also focused on companies in the healthcare and pharmaceutical sectors that are working on developing a vaccine against the coronavirus. The one that finds a vaccine first will be the main winner in the capital market. Thus, Regeneron Pharmaceuticals has increased by 58 percent since the beginning of the year, which is not surprising as Germany, France, and Spain have already ordered 500 million doses of the vaccine from whoever invents and produces it.
